2010 Annual Meeting | Update in Neuroimaging: Essentials and BeyondPart I
| 09:00 AM - 09:05 AM |
Introduction
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³» |
|
| 09:05 AM - 09:50 AM |
Advanced Neuroimaging of Brain Tumors
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FÂ鶹´«Ã½Ó³» |
|
| 09:50 AM - 10:35 AM |
Epilepsy
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³» |
|
| 10:35 AM - 10:50 AM |
Break
|
|
| 10:50 AM - 11:35 AM |
Multiple Sclerosis
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³» |
|
| 11:35 AM - 12:20 PM |
Dementia
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³» |
|
| 12:20 PM - 02:00 PM |
Lunch
|
|
| 02:00 PM - 02:40 PM |
Phakomatoses
James G. Smirniotopoulos, MD |
|
| 02:40 PM - 03:25 PM |
Stroke Imaging
Walter J. Koroshetz, MD, FÂ鶹´«Ã½Ó³» |
|
| 03:25 PM - 03:40 PM |
Break
|
|
| 03:40 PM - 04:20 PM |
Neuro-ophthalmologic Disorders
Mark J. Kupersmith, MD, FÂ鶹´«Ã½Ó³» |
|
| 04:20 PM - 05:00 PM |
Neuroimaging in the Found Down Patient
James G. Smirniotopoulos, MD |
| Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³» | Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |
| Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³» | Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. |
| Walter J. Koroshetz, MD, FÂ鶹´«Ã½Ó³» | Dr. Koroshetz has nothing to disclose. |
| Laszlo Mechtler, MD, FEAN, FASN, FAHS, FÂ鶹´«Ã½Ó³» | Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. The institution of Dr. Mechtler has received research support from Hyperfine. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Massimo Filippi, MD, FÂ鶹´«Ã½Ó³» | Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Mark J. Kupersmith, MD, FÂ鶹´«Ã½Ó³» | Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care. |
| James G. Smirniotopoulos, MD | No disclosure on file |